GA
CVS icon

Greytown Advisors’s CVS Health CVS Stock Holding History

Greytown Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,918
Closed -$309K – 80
2023
Q4 		$309K Hold
3,918
– – 0.17% 57
2023
Q3 		$274K Sell
3,918
-2,987
-43% -$212K 0.15% 62
2023
Q2 		$477K Hold
6,905
– – 0.26% 45
2023
Q1 		$513K Sell
6,905
-36
-0.5% -$3.02K 0.27% 51
2022
Q4 		$647K Sell
6,941
-1,285
-16% -$124K 0.35% 41
2022
Q3 		$785K Sell
8,226
-705
-8% -$69.8K 0.47% 31
2022
Q2 		$828K Sell
8,931
-2,272
-20% -$222K 0.47% 41
2022
Q1 		$1.13M Sell
11,203
-4,376
-28% -$460K 0.55% 34
2021
Q4 		$1.61M Sell
15,579
-1,023
-6% -$94.5K 0.68% 26
2021
Q3 		$1.41M Buy
16,602
+581
+4% +$48.7K 0.63% 27
2021
Q2 		$1.34M Buy
16,021
+3,700
+30% +$303K 0.65% 25
2021
Q1 		$927K Buy
12,321
+2,341
+23% +$171K 0.46% 36
2020
Q4 		$682K Buy
9,980
+3,110
+45% +$202K 0.47% 39
2020
Q3 		$401K Buy
+6,870
New +$427K 0.33% 55

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Greytown Advisors's CVS Position: Q1 2024 in Review

Greytown Advisors sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,918 shares — an estimated $309K sold.

Greytown Advisors first reported a position in CVS in Q3 2020 and held it in 14 quarters. The position peaked at $1.61M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Greytown Advisors reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Greytown Advisors sold 3,918 CVS Health shares in Q1 2024, an estimated $309K.
  • Greytown Advisors first reported a position in CVS Health in Q3 2020 and held it in 14 quarters.
  • Greytown Advisors's CVS Health position peaked at $1.61M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Greytown Advisors's 13F filing for Q1 2024, filed 15 May 2024.